Citi Investment Research has a $41 price target and a Hold rating on shares of UnitedHealth UNH following the company's earnings release.
In a note to clients, Citi writes, "While the bulk of United's 2011 guidance increase appears to relate to favorable prior year development, guidance includes a new one-time item — The updated outlook reflects a $0.12-0.15 per share hit related to United's portion of an assessment for a potentially insolvent long-term care company, Penn Treaty. Therefore, underlying
guidance is going up by $0.53 at the midpoint, with favorable prior year development accounting for almost half the increase. The assessment on Penn Treaty will also hit other health plans, like WellPoint."
Shares of UNH are up $3.76 to $48.00 this morning, a gain of 8.5% on more than 8 million shares.
Market News and Data brought to you by Benzinga APIs© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
Loading...
date | ticker | name | Price Target | Upside/Downside | Recommendation | Firm |
---|
Posted In: Analyst ColorPrice TargetAnalyst RatingsCiti Investment ResearchHealth CareManaged Health Care
Benzinga simplifies the market for smarter investing
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Join Now: Free!
Already a member?Sign in